Cathepsin cysteine protease inhibitors

Details for Australian Patent Application No. 2006301896 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Bayly, Christopher; Leger, Serge; Truchon, Jean-Francois

Agent Spruson & Ferguson

Pub. Number AU-A-2006301896

PCT Pub. Number WO2007/041837

Priority 60/725,774 12.10.05 US

Filing date 10 October 2006

Wipo publication date 19 April 2007

International Classifications

C07C 317/32 (2006.01) Sulfones

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

C07D 207/14 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/48 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/041837 Priority application(s): WO2007/041837

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006301897-Self actuating underreamer

2006301892-Combined use of DPP IV inhibitors and gastrin compounds